Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-21

FDA Approved: NORGESIC — Supplemental Application (Galt Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a supplemental application for NORGESIC, a combination of orphenadrine citrate, aspirin, and caffeine, manufactured by Galt Pharmaceuticals, LL…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NORGESIC (Orphenadrine citrate, aspirin and caffeine)

Snippet

SUPPL AP for NORGESIC (ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE)